Fampridine-SR Data Sends Acorda Stock Through Roof Sep. 26, 2006 By Aaron Lorenzo No Comments Shares in Acorda Therapeutics Inc. rocketed by more than 282 percent Monday on positive findings from a Phase III study of Fampridine-SR in multiple sclerosis. (BioWorld Today)Read More
Factive Gets Approvable Letter; orBec Filing Submitted to FDA Sep. 25, 2006 By Aaron Lorenzo No Comments
Factive Gets Approvable Letter; orBec Filing Submitted to FDA Sep. 25, 2006 By Aaron Lorenzo No Comments
FDA roundup: Senate committee pushes forth von Eschenbach nomination Sep. 22, 2006 By Aaron Lorenzo No Comments
